• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌患者中因子X激活活性

Factor X-activating activity in patients with colorectal carcinoma.

作者信息

Dover R, Goeting N L, Taylor I, Roath O S, Francis J L

机构信息

University Surgical Unit, Southampton General Hospital, UK.

出版信息

Br J Surg. 1987 Dec;74(12):1122-4. doi: 10.1002/bjs.1800741216.

DOI:10.1002/bjs.1800741216
PMID:3427359
Abstract

The ability of malignant tissue from 50 patients with colorectal carcinoma to activate blood coagulation factor X directly was compared with samples of adjacent, macroscopically normal colonic mucosa from the same patients, and tissue from four patients with non-malignant bowel disease. The resected tissue was homogenized and incubated with purified factor X and calcium ions. The subsequent generation of activated factor X was measured spectrophotometrically with a chromogenic substrate. Results were expressed as absorbance units, and as the ratio of tumour and normal activities. Factor X-activating activity (FXAA) was present in all normal and malignant tissues tested. FXAA was significantly greater (P less than 0.001) in the tumour homogenates than in the uninvolved tissue. The tumour:normal ratio was significantly (greater than 1.2) elevated in 38 patients (76 per cent). FXAA was not correlated with the degree of differentiation of the tumour, the Dukes' classification of the disease or the exact site of the tumour. There was no difference between the FXAA content of non-involved tissue from the colorectal cancer group and colonic mucosa from patients with non-malignant bowel disease. It is concluded that colorectal carcinomas contain significantly more FXAA than adjacent, non-malignant colonic mucosa from the same subject, but there is no direct evidence for a relationship between procoagulant levels and the extent of malignancy in these patients.

摘要

将50例结直肠癌患者的恶性组织直接激活凝血因子X的能力,与同一患者相邻的、肉眼可见正常的结肠黏膜样本以及4例非恶性肠道疾病患者的组织进行了比较。将切除的组织匀浆,并与纯化的因子X和钙离子一起孵育。随后用显色底物通过分光光度法测定活化因子X的生成量。结果以吸光度单位表示,并以肿瘤活性与正常活性的比值表示。在所有检测的正常和恶性组织中均存在因子X激活活性(FXAA)。肿瘤匀浆中的FXAA显著高于未受累组织(P小于0.001)。38例患者(76%)的肿瘤与正常组织的比值显著升高(大于1.2)。FXAA与肿瘤的分化程度、疾病的Dukes分期或肿瘤的确切部位无关。结直肠癌组未受累组织的FXAA含量与非恶性肠道疾病患者的结肠黏膜之间没有差异。结论是,结直肠癌所含的FXAA显著多于同一受试者相邻的非恶性结肠黏膜,但没有直接证据表明这些患者的促凝水平与恶性程度之间存在关联。

相似文献

1
Factor X-activating activity in patients with colorectal carcinoma.结直肠癌患者中因子X激活活性
Br J Surg. 1987 Dec;74(12):1122-4. doi: 10.1002/bjs.1800741216.
2
Factor X-activating activity in normal and malignant colorectal tissue.正常和恶性结直肠组织中的X因子激活活性。
Thromb Res. 1988 Nov 1;52(3):207-17. doi: 10.1016/0049-3848(88)90080-1.
3
Factor X-activating procoagulant in normal and malignant breast tissue.正常和恶性乳腺组织中的X因子激活促凝血剂
Hematol Oncol. 1990 Nov-Dec;8(6):323-32. doi: 10.1002/hon.2900080604.
4
Altered intracellular calcium regulation in human colorectal cancers and in "normal" adjacent mucosa.人类结直肠癌及相邻“正常”黏膜中细胞内钙调节的改变。
Cancer Res. 1991 Aug 15;51(16):4492-4.
5
Procoagulant properties of benign and malignant prostatic tissue.良性和恶性前列腺组织的促凝血特性。
Br J Urol. 1994 Aug;74(2):204-9. doi: 10.1111/j.1464-410x.1994.tb16587.x.
6
[Expression and significance of mismatch repair genes hMLH1 and hMSH2 in sporadic colorectal carcinoma].错配修复基因hMLH1和hMSH2在散发性结直肠癌中的表达及意义
Zhonghua Zhong Liu Za Zhi. 2010 Aug;32(8):590-4.
7
[Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].黏蛋白和E-钙黏蛋白在结直肠肿瘤中的表达及临床意义
Ai Zheng. 2007 Nov;26(11):1204-10.
8
Failure to demonstrate specificity of the morphological and histochemical changes in mucosa adjacent to colonic carcinoma (transitional mucosa).未能证实结肠癌旁黏膜(移行黏膜)形态学和组织化学变化的特异性。
J Clin Pathol. 1979 Mar;32(3):214-8. doi: 10.1136/jcp.32.3.214.
9
High ornithine decarboxylase activity and polyamine levels in human colorectal neoplasia.人类结直肠癌中鸟氨酸脱羧酶活性和多胺水平较高。
Ann Surg. 1986 Jul;204(1):89-93. doi: 10.1097/00000658-198607000-00013.
10
Loss of KAI1 expression in the progression of colorectal cancer.KAI1表达缺失在结直肠癌进展过程中的情况。
Cancer Res. 1999 Nov 15;59(22):5724-31.

引用本文的文献

1
D-Dimer and Carcinoembryonic Antigen Levels: Useful Indicators for Predicting the Tumor Stage and Postoperative Survival.D-二聚体和癌胚抗原水平:预测肿瘤分期和术后生存的有用指标。
Gastroenterol Res Pract. 2016;2016:4295029. doi: 10.1155/2016/4295029. Epub 2016 Aug 29.
2
Development and validation of an assay for urinary tissue factor activity.尿组织因子活性检测方法的开发与验证
J Clin Pathol. 1999 Mar;52(3):219-24. doi: 10.1136/jcp.52.3.219.
3
Plasma D-dimer level in patients with colorectal cancer: its role as a tumor marker.
结直肠癌患者的血浆D-二聚体水平:其作为肿瘤标志物的作用。
Surg Today. 1998;28(4):373-8. doi: 10.1007/s005950050144.
4
Tissue procoagulant activity may be important in sustaining metastatic tumour growth.组织促凝活性在维持转移性肿瘤生长中可能很重要。
Clin Exp Metastasis. 1992 May;10(3):175-81. doi: 10.1007/BF00132749.
5
Acquired factor X deficiency and disseminated intravascular coagulation in a case of metastasizing carcinoma of the stomach and its course under chemotherapy.
Ann Hematol. 1992 Mar;64(3):152-4. doi: 10.1007/BF01697403.
6
Non-tissue factor procoagulants in cancer cells.癌细胞中的非组织因子促凝剂。
Cancer Metastasis Rev. 1992 Nov;11(3-4):267-82. doi: 10.1007/BF01307182.
7
Tissue factor as a tumor procoagulant.组织因子作为一种肿瘤促凝剂。
Cancer Metastasis Rev. 1992 Nov;11(3-4):249-66. doi: 10.1007/BF01307181.